Helix BioPharma  
是一家致力於开发治疗和预防癌症候选药物的生物制药公司

Established by amalgamation in 1995, Helix is a publicly listed biopharmaceutical company, with its common shares listed on the Toronto Stock Exchange and Frankfurt Stock Exchange (FSE) under the symbol "HBP”.

Helix is focused on the development and commercialization of innovative medicines in the areas of cancer prevention and treatment. The Company also works to expand upon its product development pipeline through its in-house R&D efforts and potential mergers and acquisition activities.